Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
Sign Up to like & getrecommendations! Published in 2019 at "Radiology"
DOI: 10.1148/radiol.2019182953
Abstract: Background Detection of cerebral lesions at MRI may benefit from a chemically stable and more sensitively detected gadolinium-based contrast agent (GBCA). Gadopiclenol, a macrocyclic GBCA with at least twofold higher relaxivity, is currently undergoing clinical… read more here.
Keywords: gadobenate; gadobutrol; contrast; gadopiclenol ... See more keywords